Result of AGM

RNS Number : 7354V
Dechra Pharmaceuticals PLC
05 November 2010
 



Dechra® Pharmaceuticals PLC

(the "Company" or the "Group")

Results of Annual General Meeting ("AGM")

 

 

Dechra Pharmaceuticals PLC announces that all resolutions proposed at its AGM held on 5th November 2010 were duly passed on a show of hands.

 

In accordance with Listing Rule 9.6.2 and 9.6.3, copies of the resolutions (other than resolutions concerning ordinary business) passed by the Company at its AGM held on 5th November 2010 have been submitted to the National Storage Mechanism and will shortly be available for inspection at www.hemscott.com/nsm.do.

 

Details of the proxy voting instructions lodged prior to the AGM are set out below:

 

Resolution (No. as noted on proxy form)

For

Against

Discretionary

Withheld

Resolution 1: To receive and consider report and accounts

47,919,958

0

102,111

0

Resolution 2: To receive and approve Directors Remuneration Report

47,523,944

393,108

101,011

4,006

Resolution 3: To declare a final dividend

47,921,058

0

101,011

0

Resolution 4: To elect Bryan Morton

47,687,639

230,449

101,661

2,320

Resolution 5: To re-elect Edwin Torr

47,691,199

228,109

101,661

1,100

Resolution 6: To re-elect Michael Redmond

47,302,278

230,775

101,661

387,355

Resolution 7: To re-appoint KPMG Audit plc as Auditors

47,829,290

90,548

101,011

1,220

Resolution 8: To authorised the Directors to fix the Auditors remuneration

47,830,630

89,208

101,011

1,220

Resolution 9: To grant authority to allot equity securities

 

46,444,172

57,769

97,961

1,422,167

Resolution 10: To renew authority for pre-emptive allotment of equity securities

 

47,908,271

12,223

97,961

3,614

Resolution 11: To grant authority to the Company to purchase

 

47,912,955

11,153

97,961

0

Resolution 12: To call general meetings (other than an AGM) on not less than 14 clear days notice

 

47,164,556

749,386

97,961

0

Resolution 13: To approve the amendments to the Approved Share Option scheme

46,483,131

7,353

101,011

1,430,574

Resolution 14: To approve the amendments to the Unapproved Share Option scheme

47,885,211

9,793

101,011

26,054

Resolution 15: To approve the amendments to the Save as You Earn Option scheme

47,878,999

17,671

101,011

24,388

 

 

Enquiries:

Zoe Goulding, Company Secretary  

Dechra Pharmaceuticals PLC          

Tel: +44(0) 1782 771100

 

Dechra and the Dechra 'D' logo are registered Trade Mark of Dechra Pharmaceuticals PLC


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGEAKFSEELEFFF
UK 100

Latest directors dealings